Lifecore Biomedical Inc. (LFCR) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Lifecore Biomedical Inc. stock $6.32, price $6.42, that is 1.5% below the price, quality 31 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Lifecore Biomedical Inc.
LFCR · USThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.
How to read this chart
60‑month range $1.67 – $11.93 · fair‑value band $4.74 – $7.90 · the $6.42 price screens above the $6.32 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.
Every Wednesday you see whether Lifecore Biomedical is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.
Show moreShow less
It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications.
In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies.
The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Stock analysis
Lifecore Biomedical Inc. (LFCR) currently trades at $6.42, while our estimate is $6.32, so the stock looks roughly fairly valued today (gap 1.5%).
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $4.74 (bear) to $7.90 (bull), the price of $6.42 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 31/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Lifecore Biomedical Inc. reported revenue of $129M in FY2026 versus $186M in FY2022, a compound −8.6%/yr. Reported net income was −$30.8M in FY2026.
Key figures
Market cap $241M Micro · P/S ratio 2.27 · EPS (TTM) $−1.27 · Net margin −23.8% · Return on equity −76.4% · Return on assets (EBIT) −3.3% (5-year average) · Operating margin −3.5% · Revenue (TTM) $106M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (medium confidence).
What moves the price
The share trades about 27% below its 52-week high and 75% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −2%, LFCR screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, no officer or director bought or sold shares on the open market.
Plus 9 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗
Revenue & earnings trend
Growth Forecast
Watch LFCR, get fair value alerts →
Compare Lifecore Biomedical Inc. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Revenue growth by industry
- PEG ratio by industry
- Stock screener with 62 metrics
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $84.39 | $113.53 | +35% | vs LFCR |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs LFCR |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs LFCR |
| Haleon plc HLN | $9.20 | $8.47 | −8% | vs LFCR |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs LFCR |
| Galderma Group GALD | CHF 191.00 | CHF 112.46 | −41% | vs LFCR |
| Takeda Pharmaceutical Company TAK | $21.59 | $11.23 | −48% | vs LFCR |
| Teva Pharmaceutical Industries Limited TEVA | $42.57 | $20.74 | −51% | vs LFCR |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs LFCR |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs LFCR |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Lifecore Biomedical Inc. (LFCR) overvalued or undervalued?
What is the fair value of LFCR?
What is the quality score of LFCR?
What is the price target for Lifecore Biomedical Inc. (LFCR)?
What is the Lifecore Biomedical Inc. stock forecast for 2026?
What is the revenue of Lifecore Biomedical Inc. (LFCR)?
What growth is priced into Lifecore Biomedical Inc. (LFCR)?
What discount rate (WACC) does the fair value of LFCR use?
What is a reverse DCF?
How much growth has Lifecore Biomedical Inc. (LFCR) delivered so far?
How fast is the sector of Lifecore Biomedical Inc. (LFCR) growing?
What is the free cash flow yield of Lifecore Biomedical Inc. (LFCR)?
What is the intrinsic value of Lifecore Biomedical Inc. (LFCR)?
Is Lifecore Biomedical Inc. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of LFCR?
How much is Lifecore Biomedical Inc. worth?
What do the bullish and bearish scenarios say about LFCR?
What is the PEG ratio of LFCR?
How solid is the balance sheet of Lifecore Biomedical Inc. (LFCR)?
How far is LFCR from its 52-week high?
Which stocks are comparable to Lifecore Biomedical Inc.?
Is Lifecore Biomedical Inc. stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Lifecore Biomedical Inc. (LFCR)?
What should I pay attention to with Lifecore Biomedical Inc. right now?
Key figures of Lifecore Biomedical Inc.
How large is the market capitalisation of Lifecore Biomedical Inc. (LFCR)?
What is the P/S ratio of Lifecore Biomedical Inc. (LFCR)?
What are the earnings per share of Lifecore Biomedical Inc. (LFCR)?
What is the net margin of Lifecore Biomedical Inc. (LFCR)?
What is the return on equity of Lifecore Biomedical Inc. (LFCR)?
What is the EBIT return on assets of Lifecore Biomedical Inc. (LFCR)?
What is the operating margin of Lifecore Biomedical Inc. (LFCR)?
How fast is revenue growing at Lifecore Biomedical Inc. (LFCR)?
How much net debt does Lifecore Biomedical Inc. (LFCR) carry?
Watch Lifecore Biomedical Inc. in the live analysis
One click puts Lifecore Biomedical Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.